Solar Biotech's Post-Sale Ch. 11 Liquidation Gets OK
By Ben Zigterman · September 9, 2025, 1:53 PM EDT
A Delaware bankruptcy judge said Tuesday she would approve the Chapter 11 liquidation plan of Solar Biotech Inc. after it sold its assets for $20 million and resolved litigation between its largest secured...
To view the full article, register now.